News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,221 Results
Type
Article (42414)
Company Profile (294)
Press Release (673513)
Section
Business (210433)
Career Advice (2091)
Deals (36631)
Drug Delivery (106)
Drug Development (83070)
Employer Resources (175)
FDA (16564)
Job Trends (15402)
News (356050)
Policy (33915)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2590)
Accelerated approval (4)
Adcomms (21)
Allergies (84)
Alliances (51408)
ALS (87)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (117)
Approvals (16565)
Artificial intelligence (249)
Autoimmune disease (18)
Automation (14)
Bankruptcy (371)
Best Places to Work (11772)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (188)
Bladder cancer (58)
Brain cancer (27)
Breast cancer (253)
Cancer (2050)
Cardiovascular disease (171)
Career advice (1749)
Career pathing (30)
CAR-T (142)
Cell therapy (404)
Cervical cancer (19)
Clinical research (67323)
Collaboration (789)
Compensation (469)
Complete response letters (25)
COVID-19 (2656)
CRISPR (41)
C-suite (217)
Cystic fibrosis (101)
Data (1989)
Decentralized trials (2)
Denatured (26)
Depression (42)
Diabetes (253)
Diagnostics (6421)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (116)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (87915)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114601)
Executive appointments (664)
FDA (17703)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (701)
Gene editing (103)
Generative AI (20)
Gene therapy (294)
GLP-1 (724)
Government (4507)
Grass and pollen (4)
Guidances (49)
Healthcare (18999)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2789)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (89)
Interviews (322)
IPO (16765)
IRA (47)
Job creations (4059)
Job search strategy (1492)
Kidney cancer (9)
Labor market (34)
Layoffs (478)
Leadership (16)
Legal (8380)
Liver cancer (71)
Lung cancer (296)
Lymphoma (136)
Machine learning (4)
Management (59)
Manufacturing (281)
MASH (63)
Medical device (13413)
Medtech (13418)
Mergers & acquisitions (20341)
Metabolic disorders (654)
Multiple sclerosis (72)
NASH (17)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1880)
NextGen: Class of 2025 (6639)
Non-profit (4524)
Northern California (2456)
Now hiring (37)
Obesity (354)
Opinion (226)
Ovarian cancer (73)
Pain (87)
Pancreatic cancer (77)
Parkinson's disease (138)
Partnered (20)
Patents (210)
Patient recruitment (97)
Peanut (49)
People (59087)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20868)
Phase II (29611)
Phase III (22219)
Pipeline (1065)
Podcasts (75)
Policy (125)
Postmarket research (2659)
Preclinical (8843)
Press Release (68)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (376)
Real estate (6252)
Recruiting (67)
Regulatory (23026)
Reports (46)
Research institute (2367)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (72)
Series A (124)
Series B (79)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2125)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3726)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (13)
The Weekly (47)
United States (21521)
Vaccines (680)
Venture capitalists (37)
Webinars (12)
Weight loss (241)
Women's health (33)
Worklife (15)
Date
Today (116)
Last 7 days (742)
Last 30 days (2737)
Last 365 days (34052)
2025 (8366)
2024 (35774)
2023 (40643)
2022 (51803)
2021 (56345)
2020 (54797)
2019 (47408)
2018 (35780)
2017 (33145)
2016 (32673)
2015 (38626)
2014 (32537)
2013 (27657)
2012 (29752)
2011 (30497)
2010 (28501)
Location
Africa (782)
Alabama (49)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40605)
Australia (6504)
California (5600)
Canada (1888)
China (488)
Colorado (250)
Connecticut (257)
Delaware (131)
Europe (86631)
Florida (830)
Georgia (196)
Idaho (57)
Illinois (513)
India (25)
Indiana (300)
Iowa (9)
Japan (146)
Kansas (100)
Kentucky (23)
Louisiana (8)
Maine (61)
Maryland (841)
Massachusetts (4254)
Michigan (211)
Minnesota (372)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1606)
New Mexico (29)
New York (1609)
North Carolina (942)
North Dakota (7)
Northern California (2456)
Ohio (192)
Oklahoma (14)
Oregon (38)
Pennsylvania (1270)
Puerto Rico (9)
Rhode Island (27)
South America (1160)
South Carolina (18)
South Dakota (1)
Southern California (2125)
Tennessee (94)
Texas (841)
Utah (166)
Virginia (138)
Washington D.C. (57)
Washington State (522)
West Virginia (3)
Wisconsin (51)
716,221 Results for "janssen pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
AbelZeta Announces Amendment to Worldwide Collaboration and License Agreement with Janssen to Include China
AbelZeta Pharma, Inc. announced an amendment of its worldwide collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.
December 14, 2023
·
5 min read
Business
Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza
Cidara Therapeutics, Inc. has announced that Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has delivered to Cidara its Election to Proceed Notice for CD388 (JNJ-0953) which is being developed for the universal prevention of influenza A and B.
September 6, 2023
·
5 min read
Business
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen).
January 5, 2024
·
3 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Business
Predicine Announces Collaboration with Janssen to Develop PredicineCARE™ as a Companion Diagnostic Assay in Localized Bladder Cancer
Predicine, Inc., a leading molecular insights company, announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company.
January 8, 2024
·
2 min read
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (“Janssen PMP”) are pleased to announce a significant expansion to their existing Exclusive Evaluation and Option Agreement
September 6, 2023
·
9 min read
Policy
IBM Addresses Data Incident for Janssen CarePath Database
IBM is notifying Janssen CarePath customers and users of an incident involving unauthorized access to personal information contained within a database used on the Janssen CarePath platform, a patient support platform that offers savings options and other patient support resources.
September 6, 2023
·
2 min read
Press Releases
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
March 25, 2025
·
4 min read
Genetown
Elektrofi and Janssen Biotech Enter Worldwide Collaboration and License Agreement to Exclusively Develop up to Five Programs Utilizing Elektrofi’s Formulation Technology
Elektrofi, Inc. announced that it has entered a multi-target worldwide research collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.
January 3, 2024
·
2 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
April 3, 2025
·
5 min read
1 of 71,623
Next
